文献速递糖尿病肥胖与代谢综合征

宫内暴露于母亲糖尿病的个体基因差异甲基化研究

Differential methylation of genes in individuals exposed to maternal diabetes in utero.
PubMed 文献 · Diabetologia · 2017-01-26

在388名皮马印第安人中开展全表观基因组关联研究,比较宫内暴露于2型糖尿病母亲(OMD,187人)与未暴露(OMND,201人)的DNA甲基化差异。鉴定出48个差异甲基化CpG位点,映射至29个基因和10个基因间区;LHX3、PRDM16等位点甲基化改变与胰岛素分泌功能下降、BMI及未来糖尿病风险相关。

要点

  • 宫内暴露于母亲糖尿病与48个CpG位点差异甲基化相关,涉及29个基因。
  • PRDM16附近CpG高甲基化预测未来糖尿病风险(HR 2.12/SD,p=9.7×10⁻⁵)。
  • AK3、PCDHGA4、STC1甲基化改变与血糖正常后代胰岛素分泌功能下降相关。

核心结论

  • 宫内暴露于糖尿病可影响多个基因组位点的甲基化,部分位点甲基化状态可损害胰岛素分泌、增加体重并增加2型糖尿病风险。

研究设计与样本

  • 全表观基因组关联研究,采用Illumina HumanMethylation450K BeadChip检测外周血DNA甲基化。
  • 共分析423,311个CpG位点,纳入388名皮马印第安人,检查时平均年龄13.0岁,其中OMD 187人、OMND 201人。

主要发现

  • 鉴定出48个差异甲基化CpG位点(经验错误发现率≤0.05),映射至29个基因和10个基因间区。
  • LHX3基因有6个CpG位点在OMD中较OMND高甲基化(p≤1.1×10⁻⁵),证据最强。
  • PRDM16附近CpG在OMD中高甲基化(高1.1%,p=5.6×10⁻⁷),且该高甲基化预测未来糖尿病风险(甲基化每增加1个SD,HR 2.12,p=9.7×10⁻⁵)。
  • AK3附近高甲基化(高2.5%,p=7.8×10⁻⁶)、PCDHGA4低甲基化(低2.8%,p=3.0×10⁻⁵)和STC1低甲基化(低2.9%,p=1.6×10⁻⁵)与宫内糖尿病暴露相关,并与血糖正常后代胰岛素分泌功能下降相关(AK3:甲基化每增加1个SD,胰岛素分泌功能降低0.088 SD,p=0.02;PCDHGA4:甲基化每降低1个SD,降低0.08 SD,p=0.03;STC1:甲基化每降低1个SD,降低0.072 SD,p=0.05)。
  • 17个CpG位点与BMI相关(p≤0.05)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Individuals exposed to maternal diabetes in utero are more likely to develop metabolic and cardiovascular diseases later in life. This may be partially attributable to epigenetic regulation of gene expression. We performed an epigenome-wide association study to examine whether differential DNA methylation, a major source of epigenetic regulation, can be observed in offspring of mothers with type 2 diabetes during the pregnancy (OMD) compared with offspring of mothers with no diabetes during the pregnancy (OMND). METHODS: DNA methylation was measured in peripheral blood using the Illumina HumanMethylation450K BeadChip. A total of 423,311 CpG sites were analysed in 388 Pima Indian individuals, mean age at examination was 13.0 years, 187 of whom were OMD and 201 were OMND. Differences in methylation between OMD and OMND were assessed. RESULTS: Forty-eight differentially methylated CpG sites (with an empirical false discovery rate ≤0.05), mapping to 29 genes and ten intergenic regions, were identified. The gene with the strongest evidence was LHX3, in which six CpG sites were hypermethylated in OMD compared with OMND (p ≤ 1.1 × 10-5). Similarly, a CpG near PRDM16 was hypermethylated in OMD (1.1% higher, p = 5.6 × 10-7), where hypermethylation also predicted future diabetes risk (HR 2.12 per SD methylation increase, p = 9.7 × 10-5). Hypermethylation near AK3 and hypomethylation at PCDHGA4 and STC1 were associated with exposure to diabetes in utero (AK3: 2.5% higher, p = 7.8 × 10-6; PCDHGA4: 2.8% lower, p = 3.0 × 10-5; STC1: 2.9% lower, p = 1.6 × 10-5) and decreased insulin secretory function among offspring with normal glucose tolerance (AK3: 0.088 SD lower per SD of methylation increase, p = 0.02; PCDHGA4: 0.08 lower SD per SD of methylation decrease, p = 0.03; STC1: 0.072 SD lower per SD of methylation decrease, p = 0.05). Seventeen CpG sites were also associated with BMI (p ≤ 0.05). Pathway analysis of the genes with at least one differentially methylated CpG (p < 0.005) showed enrichment for three relevant biological pathways. CONCLUSIONS/INTERPRETATION: Intrauterine exposure to diabetes can affect methylation at multiple genomic sites. Methylation status at some of these sites can impair insulin secretion, increase body weight and increase risk of type 2 diabetes.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Chen P, Piaggi P, Traurig M, et al. Differential methylation of genes in individuals exposed to maternal diabetes in utero. Diabetologia. 2017. PMID: 28127622. doi:10.1007/s00125-016-4203-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。